
TWO BROTHERS FROM MACEDONIA WITH GITELMAN SYNDROME Janchevska A, Tasic V, Jordanova O, Gucev Z, Jenkins L, Jovanovska N, Plaseska – Karanfilska D, Ashton E, Bockenhauer D *Corresponding Author: Ass. Prof. Dr. Aleksandra Janchevska, University Children’s hospital, Skopje, Rep. of N. Macedonia; Email: dr.sasha1969@yahoo.com page: 69
|
CASE REPORT
A 7-year-old boy was admitted with episodes of carpopedal
spasms and muscle aches, after vomiting in the
preceding months. He was born at term, in the 39th gestation
week of a normal pregnancy, with a birth weight
(BW) of 3150gr (-0.58 SDS) and length (BL) 50cm (-0.04
SDS). His past medical history and family history were
unremarkable.
The carpopedal spasms and muscle aches later also
manifested in his younger brother at the age of 7.5 years.
His birth parameters, BW of 3670gr (0.23 SDS) and BL
(0.16 SDS) were also within reference range with an otherwise
unremarkable past medical history.
The boys’ height (-0.5 SDS in older versus -0.91
SDS in younger brother) and weight (1.24 SDS versus
-1.96 SDS) and pubertal stage, A1B1P1, at the onset of
symptoms, and during the follow-up period, have been
appropriate for their sex and age.
Our patients never had clinical signs of dehydration.
The initial and follow-up measured biochemical parameters
revealed electrolyte imbalances shown in Tables
1a and 1b.
The serum parameters of hepatic and renal function
were within reference range, as were those for parathyroid
and thyroid function. Although hypokalemia and
hypomagnesemia may contribute to prolongation of the
Q-T interval [8], the performed electrocardiogram and the
measured Q-T interval (0.36 sec) were normal, as were
kidney ultrasound, audiogram and electroencephalogram.
The molecular analysis was performed after written
informed consent had been obtained from the parents. A
next generation sequencing (NGS) panel, as described
previously [12] was used and revealed in the older brother
three heterozygous variants in SLC12A3 (NM_000339.3):
c.1805_1806del, c.2660+1G>A and c.2944 A>T, all confirmed
by Sanger sequence analysis. The same constellation
was found in the younger brother.
Their mother was found to be heterozygous for the
c.2944 A>T; p. (Ile982Phe) pathogenic variant and their
asymptomatic father was heterozygous for the other two
pathogenic variants SLC12A3 c.1805_1806del; p. (Tyr-
602Cysfs*31) and c.2660+1G>A, thus confirming that
these two variants are on the same allele.
The paternal variants are considered pathogenic.
The c.2660+1G>A variant affects the canonical donor
splice site of exon 22 and has been recurrently identified
in Gitelman syndrome [12, 13]. The other variant results
in a frameshift. Thus, both are null variants (PVS1), that
are absent in controls (PM2) and in a gene that is highly
specific for the phenotype (PP3) and are thus annotated
as pathogenic.
The maternal variant c.2944 A>T; p. (Ile982Phe) is
absent in controls (PM2) and was found in trans with a
pathogenic variant (PM3). In silico tools predict that this
variant is likely damaging (PP3) and as the phenotype is
highly specific for this gene (PP4), this variant was classified
as likely pathogenic.
The boys were advised to maintain an increased salt
intake and were prescribed oral potassium and magnesium
supplements. The follow up period has been uneventful
with occasional episodes of paresthesia.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|